Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 01, 2023 17:30 ET | Source: Avicanna Inc.

Retirement of Chandra Panchal, PhD from the Board of Directors

TORONTO, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing,...
August 15, 2023 07:30 ET | Source: Avicanna Inc.

Avicanna Reports Q2 2023 Financial Statement

TORONTO, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and...
August 02, 2023 19:50 ET | Source: Avicanna Inc.

Avicanna Announces Closing of Non-Brokered Private Placement of Debenture Units

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES...
August 01, 2023 07:30 ET | Source: Avicanna Inc.

Avicanna Announces Closing of Acquisition and Launch of MyMedi.ca

Completed the acquisition of the Medical Cannabis by Shopper’s Drug Mart business. Launch of Avicanna’s new medical cannabis care platform MyMedi.ca. TORONTO, Aug. 01, 2023 (GLOBE NEWSWIRE) --...
July 28, 2023 07:30 ET | Source: Avicanna Inc.

Avicanna is Pleased to Announce the Initial Network of Brands on the MyMedi.ca Platform

The MyMedi.ca medical cannabis care platform is preparing to launch August 1, 2023 The new cannabis care platform will offer a diverse portfolio of products, including 35 brands and over 200 SKUs...
July 17, 2023 07:30 ET | Source: Avicanna Inc.

Avicanna Subsidiary SMGH Exports Aureus Branded CBD and CBG Into Paraguay

TORONTO, July 17, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and...
June 28, 2023 07:30 ET | Source: Avicanna Inc.

Avicanna Provides Corporate Update and Preliminary Q2 Results

TORONTO, June 28, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and...
June 26, 2023 07:30 ET | Source: Avicanna Inc.

Avicanna and Medipharm Labs Expand Strategic Manufacturing Agreement for Avicanna’s Proprietary SEDDS Technology Capsules for Canadian and International markets

Avicanna’s proprietary SEDDS technology capsules are designed for enhanced and rapid absorption of cannabinoids. Avicanna and Medipharm intend to commercialize various formulations of Avicanna’s...
June 22, 2023 07:30 ET | Source: Avicanna Inc.

Avicanna Sponsors New Medical Cannabis Education and Training Campaign in Canada with the Canadian Consortium for the Investigation of Cannabinoids (“CCIC”)

TORONTO, June 22, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on...
June 13, 2023 07:30 ET | Source: Avicanna Inc.

Avicanna and Langara College Announce Cannabinoid-Based Translational Research Collaboration and NSERC Grant

This Research Collaboration will be led by Dr. Jessica Kalra’s research team and focus on characterization of Avicanna’s proprietary products and drug pipeline formulations This Research...